129 related articles for article (PubMed ID: 19694498)
1. TrkB as a therapeutic target for ovarian cancer.
Siu MK; Wong OG; Cheung AN
Expert Opin Ther Targets; 2009 Oct; 13(10):1169-78. PubMed ID: 19694498
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
Au CW; Siu MK; Liao X; Wong ES; Ngan HY; Tam KF; Chan DC; Chan QK; Cheung AN
Cancer Lett; 2009 Aug; 281(2):151-61. PubMed ID: 19307055
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients?
Han L; Zhang Z; Qin W; Sun W
Med Hypotheses; 2007; 68(2):407-9. PubMed ID: 17008023
[TBL] [Abstract][Full Text] [Related]
5. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
[TBL] [Abstract][Full Text] [Related]
7. TrkB inhibition as a therapeutic target for CNS-related disorders.
Boulle F; Kenis G; Cazorla M; Hamon M; Steinbusch HW; Lanfumey L; van den Hove DL
Prog Neurobiol; 2012 Aug; 98(2):197-206. PubMed ID: 22705453
[TBL] [Abstract][Full Text] [Related]
8. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
9. Neonatal maternal separation increases brain-derived neurotrophic factor and tyrosine kinase receptor B expression in the descending pain modulatory system.
Chung EK; Bian ZX; Xu HX; Sung JJ
Neurosignals; 2009; 17(3):213-21. PubMed ID: 19546592
[TBL] [Abstract][Full Text] [Related]
10. The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.
Zage PE; Graham TC; Zeng L; Fang W; Pien C; Thress K; Omer C; Brown JL; Zweidler-McKay PA
Cancer; 2011 Mar; 117(6):1321-91. PubMed ID: 20960503
[TBL] [Abstract][Full Text] [Related]
11. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
Zhu L; Werner JA; Mandic R
Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
Cimmino F; Schulte JH; Zollo M; Koster J; Versteeg R; Iolascon A; Eggert A; Schramm A
Oncogene; 2009 May; 28(19):2015-23. PubMed ID: 19363525
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia.
Pillai A
Neurosignals; 2008; 16(2-3):183-93. PubMed ID: 18253057
[TBL] [Abstract][Full Text] [Related]
14. TrkB partial agonists: potential treatment strategy for major depression.
Tsai SJ
Med Hypotheses; 2007; 68(3):674-6. PubMed ID: 16905274
[TBL] [Abstract][Full Text] [Related]
15. Acceleration of methylmercury-induced cell death of rat cerebellar neurons by brain-derived neurotrophic factor in vitro.
Sakaue M; Mori N; Makita M; Fujishima K; Hara S; Arishima K; Yamamoto M
Brain Res; 2009 Jun; 1273():155-62. PubMed ID: 19332029
[TBL] [Abstract][Full Text] [Related]
16. BDNF/TrkB signaling as an anti-tumor target.
Roesler R; de Farias CB; Abujamra AL; Brunetto AL; Schwartsmann G
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1473-5. PubMed ID: 21999118
[No Abstract] [Full Text] [Related]
17. Targeting signaling pathways in ovarian cancer.
Reibenwein J; Krainer M
Expert Opin Ther Targets; 2008 Mar; 12(3):353-65. PubMed ID: 18269344
[TBL] [Abstract][Full Text] [Related]
18. Early exercise in spinal cord injured rats induces allodynia through TrkB signaling.
Endo T; Ajiki T; Inoue H; Kikuchi M; Yashiro T; Nakama S; Hoshino Y; Murakami T; Kobayashi E
Biochem Biophys Res Commun; 2009 Apr; 381(3):339-44. PubMed ID: 19222991
[TBL] [Abstract][Full Text] [Related]
19. BDNF and TrkB in the preterm and near-term ovine fetal brain and the effect of intermittent umbilical cord occlusion.
Nishigori H; Mazzuca DM; Nygard KL; Han VK; Richardson BS
Reprod Sci; 2008 Nov; 15(9):895-905. PubMed ID: 19050322
[TBL] [Abstract][Full Text] [Related]
20. BDNF activates TrkB/PLCĪ³1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
